S303: A PHASE 3 STUDY (ATLAS-PPX) TO EVALUATE EFFICACY AND SAFETY OF FITUSIRAN IN PEOPLE WITH HAEMOPHILIA A OR B WHO HAVE SWITCHED FROM PRIOR CLOTTING FACTOR CONCENTRATE OR BYPASSING AGENT PROPHYLAXIS

Detalles Bibliográficos
Autores principales: Kenet, Gili, Nolan, Beatrice, Zulfikar, Bulent, Antmen, Bulent, Kampmann, Peter, Matsushita, Tadashi, You, Chur-Woo, Vilchevska, Kateryna, Bag, Catherine N., Sharif, Azizan, Peyvandi, Flora, Young, Guy, Negrier, Claude, Sussebach, Christian, Shammas, Fadi, Andersson, Shauna, Mei, Baisong, Kavakli, Kaan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Oral Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428383/
http://dx.doi.org/10.1097/01.HS9.0000968124.64352.6e

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428383/
http://dx.doi.org/10.1097/01.HS9.0000968124.64352.6e

Ejemplares similares